ARCHIVEPost of Slovenia Writes a Letter to the Dog in a Direct Mail Campaign
How Post of Slovenia Used a Letter to a Dog to Defend the Emotional Case for Mail Post of...
Merck and McCann Health London Reframe Twenty Years of MS
"The Journey" is a 2018 documentary-style film created by McCann Health London for Merck, released in the United Kingdom in September 2018 to mark World MS Day, tracing an emotional patient narrative across two decades of life with multiple sclerosis.
The campaign originated from a significant corporate milestone. The film marked 20 years since Merck introduced a treatment for multiple sclerosis, as documented on adsoftheworld.com. Rather than position the anniversary as a product celebration, McCann Health London reframed it as a human story — following a patient from the moment of diagnosis through twenty years of lived experience with MS. That structural choice transformed what could have been conventional pharmaceutical advertising into disease-awareness communication, classified by the agency itself as a corporate and advocacy piece rather than direct product promotion.
The campaign launched exclusively in the United Kingdom and was submitted to international awards bodies under that geography, as confirmed by the Clio Health 2018 entry documented on The Clio Awards. The single film asset carried the entire creative weight of the campaign, with no supplementary print, out-of-home, or digital extensions recorded in available sources. This compression of message into one cinematic piece reflected a broader shift across healthcare communications in 2018 toward long-form, emotionally resonant content designed to build brand trust rather than drive immediate prescription behaviour. The Clapboard Score for this campaign is 62 out of 100, reflecting strong craft credentials and award recognition offset by a limited media footprint and the absence of publicly verified performance metrics.
Merck KGaA operates in a highly competitive global pharmaceutical environment. The global pharmaceutical market was estimated at approximately 952 billion US dollars in 2018, according to researchandmarkets.com, with nervous-system medicines identified as one of the major growth categories alongside oncology and immunology, as reported by pharmaceutical-technology.com. Within that context, the multiple sclerosis treatment segment was among the most contested areas of neurology, with competitors including Biogen and Novartis holding established MS portfolios that commanded significant patient and prescriber attention in the United Kingdom.
Merck's strategic decision to anchor communications around World MS Day demonstrated an understanding that disease-awareness platforms can achieve what product campaigns cannot: permission to speak directly to the lived reality of patients rather than to clinical endpoints. In the United Kingdom, where the National Health Service shapes prescribing environments and patient trust in pharmaceutical brands is historically measured, this approach carried particular strategic logic. A film that centred patient experience over product features reduced the friction that UK audiences typically apply to branded healthcare content.
The campaign was also timed to coincide with the 20-year anniversary of Merck's MS treatment history, as noted on adsoftheworld.com. That longevity argument — two decades of commitment to patients living with multiple sclerosis — gave the brand a durable differentiator against newer market entrants. McCann Health London built the strategy around that heritage, using documentary technique to make the passage of twenty years emotionally legible rather than merely chronological. The result was a campaign designed to strengthen Merck's authority in MS care among both patients and healthcare professionals across the UK market.
"The Journey" was directed by Rob Chiu, with Rina Yang serving as director of photography, as documented in the New York Festivals Advertising Awards 2018 entry listed on nyfadvertising.com. Adrian Parr held the role of Executive Creative Director, EMEA, at McCann Health London, as recorded on adsoftheworld.com. The presence of this specific creative leadership shaped a film that prioritised visual restraint and emotional authenticity over the declarative graphics and voice-over conventions common to pharmaceutical advertising.
The cinematographic approach that earned the campaign a Finalist Certificate in Film Craft under the Cinematography category at the New York Festivals Advertising Awards 2018, per nyfadvertising.com, reflected a documentary sensibility rarely deployed in prescription-drug communications. Rina Yang's work as director of photography established a visual grammar grounded in naturalistic light and observational framing — techniques that position the viewer as witness rather than audience, which is a meaningful distinction in healthcare storytelling where trust is the primary currency.
Rob Chiu's direction gave the film its structural coherence across a compressed timeline. Portraying two decades of a patient's life with multiple sclerosis within a single cinematic piece required precise editorial and tonal control to avoid sentimentality while sustaining emotional engagement. The decision to treat the patient journey as a continuous narrative arc — rather than segmenting it into disease-stage vignettes — gave the film a dramatic unity that distinguished it from comparable disease-awareness content in the United Kingdom at the time. Production credits beyond those named above for this campaign are not fully documented in publicly available sources.
No verified commercial performance data for "The Journey" — including reach figures, view counts, or prescription-influence metrics — is publicly available. The campaign's measurable impact is therefore assessed through its awards record and structural effectiveness.
The film received a Bronze award at Clio Health 2018 in the Health and Wellness category under Film Technique and specifically Cinematography, as documented on clios.com. The Clio Health awards represent one of the most scrutinised peer-review processes in global healthcare advertising, making a Bronze recognition in a craft-specific subcategory a meaningful signal of production quality. The same campaign earned a Finalist Certificate in Film Craft under Cinematography at the New York Festivals Advertising Awards 2018, as recorded on nyfadvertising.com, reinforcing the consistent assessment of the film's visual quality across two independent juries.
Both awards were entered under the McCann Health London agency name, with the brand listed as Merck and Rebif in New York Festivals documentation per nyfadvertising.com, confirming the campaign's connection to Merck's MS treatment portfolio while maintaining the disease-awareness framing. Structurally, the campaign's strength lies in its decision to compress an entire treatment era into a single film, allowing Merck to claim narrative ownership of a patient's twenty-year journey in the United Kingdom. That architecture builds institutional credibility more durably than campaign-cycle media buys, though the absence of multi-channel amplification likely constrained total audience reach.
"The Journey" is a 2018 documentary-style film created by McCann Health London for Merck, released in the United Kingdom in September 2018. It portrays a patient's emotional experience from MS diagnosis across two decades, marking twenty years since Merck introduced a multiple sclerosis treatment, as documented on adsoftheworld.com.
Rob Chiu directed "The Journey," with Rina Yang as director of photography, as recorded in the New York Festivals Advertising Awards 2018 entry on nyfadvertising.com. Adrian Parr served as Executive Creative Director, EMEA, at McCann Health London. Their combined craft approach earned the film recognition in cinematography categories at two international awards bodies.
"The Journey" received a Bronze award at Clio Health 2018 in the Health and Wellness category under Film Technique and Cinematography, as documented on clios.com. The film also earned a Finalist Certificate in Film Craft under Cinematography at the New York Festivals Advertising Awards 2018, per nyfadvertising.com, confirming cross-jury recognition of its production quality.
McCann Health London chose documentary technique to position Merck as a long-term partner in MS care rather than a product advertiser. In the United Kingdom, where NHS-shaped audiences apply scrutiny to branded healthcare content, a patient-centred film framed as disease awareness reduced friction and allowed direct engagement with the lived reality of multiple sclerosis.
"The Journey" is classified as corporate and disease-awareness communication rather than conventional product advertising, as confirmed by entry documentation on adsoftheworld.com and clios.com. While New York Festivals records list the brand as Merck and Rebif per nyfadvertising.com, the film's narrative centres on patient experience across twenty years rather than treatment claims.
World MS Day gave Merck a globally recognised platform to anchor its 20-year MS treatment anniversary in the United Kingdom. The timing connected an institutional milestone to a patient-advocacy moment, allowing McCann Health London to frame Merck's pharmaceutical heritage as a commitment to people living with multiple sclerosis rather than a commercial achievement.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
.jpg&w=256&q=75)
